CANNABINOID RECEPTOR LIGAND

Japanese Patent JP2009024011

A

To provide a cannabinoid receptor ligand.

A compound of formula (I), a prodrug thereof or a pharmaceutically acceptable salt, solvate or stereoisomer of the compound or of the prodrug, all of which exhibiting anti-inflammatory and immunomodulatory activity, are provided. Also provided are a pharmaceutical composition containing the compounds and methods of use of the compounds for treating various diseases and conditions.

KOZLOWSKI JOSEPH A
SHIH NENG-YANG
LAVEY BRIAN J
RIZVI RAZIA K
SHANKAR BANDARPALLE B
SPITLER JAMES M
TONG LING
WOLIN RONALD
WONG MICHAEL K

JP2008186568A

February 05, 2009

July 17, 2008

Click for automatic bibliography generation  

SCHERING CORP

C07C317/32; A61K31/12; C07C317/50; A61K31/165; A61K31/17; A61K31/18; A61K31/277; A61K31/341; A61K31/365; A61K31/381; A61K31/415; A61K31/4164; A61K31/42; A61K31/44; A61K31/4402; A61K31/4425; A61K31/47; A61K31/495; A61K31/505; A61K31/519; A61K31/5375; A61K31/5415; A61K31/573; A61K31/635; A61K31/785; A61K38/00; A61K38/21; A61K45/00; A61P1/04; A61P1/16; A61P3/10; A61P9/00; A61P9/10; A61P9/14; A61P11/00; A61P11/02; A61P11/06; A61P11/08; A61P11/16; A61P13/12; A61P17/00; A61P17/02; A61P17/06; A61P19/02; A61P19/10; A61P21/04; A61P25/00; A61P27/02; A61P27/06; A61P29/00; A61P31/04; A61P35/00; A61P35/02; A61P37/00; A61P37/02; A61P37/06; A61P37/08; A61P43/00; C07C31/24; C07C217/56; C07C233/32; C07C317/22; C07C317/36; C07C317/44; C07C317/46; C07C323/32; C07C323/41; C07C323/49; C07C323/62; C07C323/65; C07D213/70; C07D213/71; C07D213/74; C07D213/89; C07D215/36; C07D231/12; C07D233/42; C07D233/84; C07D239/38; C07D261/18; C07D295/18; C07D295/20; C07D307/58; C07D307/64; C07D333/20; C07D333/34; C07D333/38; C07D417/12; C07D475/10; C07J7/00

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: METHOD FOR PREPARING TERTIARY ALKYL ESTER OF (METH)ACRYLIC ACID WITH AT LEAST 4 CARBON ATOMS IN ALKY...

Next Patent: DENTAL COMPOSITE HAVING LOW SHRINKAGE STRAIN AND HIGH FLEXURAL STRENGTH